Drug Shortage Report for THEO ER
Report ID | 240630 |
Drug Identification Number | 02360128 |
Brand name | THEO ER |
Common or Proper name | THEO ER |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | THEOPHYLLINE |
Strength(s) | 600MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | R03DA |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-10-18 |
Estimated end date | 2024-10-31 |
Actual end date | 2024-10-29 |
Shortage status | Resolved |
Updated date | 2024-10-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-10-31 | French | Compare |
v6 | 2024-10-31 | English | Compare |
v5 | 2024-10-24 | French | Compare |
v4 | 2024-10-24 | English | Compare |
v3 | 2024-10-19 | English | Compare |
v2 | 2024-10-18 | French | Compare |
v1 | 2024-10-18 | English | Compare |
Showing 1 to 7 of 7